JobRunr Introduces ClawRunr Open-Source Agent Runtime in Pure Java. By ADTMag.com Editors; May 5, 2026; JobRunr, a software company that develops an eponymous, open-source Java li ...

Home security giant ADT has confirmed a data breach after the ShinyHunters extortion group threatened to leak stolen data unless a ransom is paid. In a statement shared today, the company said it ...

ADT is launching a new feature for its ADT+ service, with “My Safety” able to turn your phone into a portable security system, including a useful always-listening “Emergency Phrase.” Rolling out now ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Home and small-business security company ADT is all about making people feel safe. Now, as a result of a partnership with financial wellness platform Addition Wealth, its employees are feeling more ...

Tyler has worked on, lived with and tested all types of smart home and security technology for over a dozen years, explaining the latest features, privacy tricks, and top recommendations. With degrees ...

BOCA RATON, Fla. — ADT, a provider of smart home solutions serving residential and small business customers in the U.S., has announced that it has acquired Origin Wireless, Inc. (d/b/a “Origin AI” and ...

ADT (Nasdaq: ADT) has acquired Origin Wireless, bringing the company’s AI sensing platform and related intellectual property into the ADT ecosystem in a move aimed at advancing intelligent home ...

ADT is a defensive, cash-generative business trading below intrinsic value, assuming it increases its ROIC. State Farm and Apollo, holding ~27% combined, may sell shares, potentially pressuring ADT’s ...

Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...

Androgen deprivation therapy (ADT), also called hormone therapy, is a common treatment for metastatic prostate cancer. It works by starving the cancer of testosterone, which fuels the tumor’s growth.